|Name||French Embassy in Berlin/ Französische Botschaft in Berlin|
|Stadt||10117 Berlin, Deutschland|
The Berlin Conference on IP in Life Sciences has become a must-attend for life sciences decision makers, IP and legal experts, business developers and investors. The upcoming event will explore the potential of digital health technologies for the Life Sciences sector and discuss relevant interfaces of the pharma, biotechnology, medical care and IT sector.
Against the background of an ongoing digital change progress, the conference is designed to provide deep insights into the e-Health market conditions across Europe and beyond. It will highlight the most important next generation IT and personalised medicine solutions which provide pharma, diagnostics and medical care companies with new tools to delevelop treatments and diagnostics, to deliver a better experience to patients, to improve clinical outcomes and to reduce total costs.
Further topics covered during the conference include the impact of IT on Life Science R&D as well as on translational medicine, challenges of big data in the clinical environment as well as the role life science companies are able to play within the new set-up of doctor-to-doctor and doctor-to-patient communication. Furthermore, legal issues regarding the use and the patenting of new digital health products will be discussed.
Speakers cover the whole value chain from research to the market. Among others, presentations from Sanofi, myTomorrows, Qualcomm Life Europe, Molecular Health, Roland Berger, Kurma Partners, Vossius & Partner, INRIA, Hasso-Plattner-Institut and INPI will be held during the conference. see programme